Xunyi Luo

1.0k total citations
8 papers, 162 citations indexed

About

Xunyi Luo is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xunyi Luo has authored 8 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xunyi Luo's work include Platelet Disorders and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Xunyi Luo is often cited by papers focused on Platelet Disorders and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Xunyi Luo collaborates with scholars based in United States, Canada and Italy. Xunyi Luo's co-authors include Careen K. Tang, Xiaoqi Gong, Yufang Shi, Graham Jamieson, Giovanni Tonon, Weidong Chen, Nicholas J. Greco, Ruoxiang Wang, José L. Moreno and Xiaoren Zhang and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Xunyi Luo

8 papers receiving 156 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xunyi Luo United States	7	68	40	38	22	21	8	162
Gantulga Davaakhuu Japan	9	171 2.5×	31 0.8×	35 0.9×	5 0.2×	22 1.0×	19	331
Claudia Stoeger Germany	5	163 2.4×	34 0.8×	31 0.8×	14 0.6×	10 0.5×	6	270
Soo Min United States	9	73 1.1×	95 2.4×	55 1.4×	6 0.3×	4 0.2×	12	287
Ana Bastos-Carvalho United States	6	198 2.9×	60 1.5×	9 0.2×	8 0.4×	33 1.6×	10	320
Matthew C. Sims United Kingdom	5	102 1.5×	9 0.2×	26 0.7×	9 0.4×	7 0.3×	7	181
Riitta Sallinen Finland	9	97 1.4×	53 1.3×	13 0.3×	9 0.4×	3 0.1×	12	212
Ivana Apicella United States	10	144 2.1×	57 1.4×	29 0.8×	9 0.4×	8 0.4×	16	259
Olaya Santiago‐Fernández United States	8	202 3.0×	26 0.7×	27 0.7×	8 0.4×	6 0.3×	10	294
Silvia G. Vaena United States	7	103 1.5×	51 1.3×	42 1.1×	8 0.4×	5 0.2×	13	202
Helena Manso Portugal	6	101 1.5×	46 1.1×	17 0.4×	21 1.0×	2 0.1×	6	228

Countries citing papers authored by Xunyi Luo

Since Specialization

Citations

This map shows the geographic impact of Xunyi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xunyi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xunyi Luo more than expected).

Fields of papers citing papers by Xunyi Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xunyi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xunyi Luo. The network helps show where Xunyi Luo may publish in the future.

Co-authorship network of co-authors of Xunyi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xunyi Luo. A scholar is included among the top collaborators of Xunyi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xunyi Luo. Xunyi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Mason, Jacqueline M., Xunyi Luo, Vincent Nadeem, et al.. (2011). Abstract LB-215: Inhibition of Polo-like kinase 4 as an anti-cancer strategy. Cancer Research. 71(8_Supplement). LB–215. 4 indexed citations

Yu, Hong, Xiaoqi Gong, Xunyi Luo, et al.. (2008). Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways. Cancer Biology & Therapy. 7(11). 1818–1828. 24 indexed citations

Oort, Pieter J., Trina A. Knotts, Michel Grino, et al.. (2008). γ-Synuclein Is an Adipocyte-Neuron Gene Coordinately Expressed with Leptin and Increased in Human Obesity , ,3. Journal of Nutrition. 138(5). 841–848. 26 indexed citations

Yuan, Zengrong, Ruoxiang Wang, Xunyi Luo, et al.. (2005). Identification and Characterization ofSurvival-Related Gene, a Novel Cell Survival Gene Controlling Apoptosis and Tumorigenesis. Cancer Research. 65(23). 10716–10724. 7 indexed citations

Luo, Xunyi, Xiaoqi Gong, & Careen K. Tang. (2003). Suppression of EGFRvIII‐mediated proliferation and tumorigenesis of breast cancer cells by ribozyme. International Journal of Cancer. 104(6). 716–721. 22 indexed citations

Tonon, Giovanni, Xunyi Luo, Nicholas J. Greco, et al.. (2002). Weak platelet agonists and U46619 induce apoptosis-like events in platelets, in the absence of phosphatidylserine exposure. Thrombosis Research. 107(6). 345–350. 24 indexed citations

Wang, Ruoxiang, Liying Zhang, Xiaoren Zhang, et al.. (2001). Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-κB Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-α During T Cell Activation. The Journal of Immunology. 166(3). 1983–1990. 29 indexed citations

Greco, Nicholas J., et al.. (2001). Novel structurally altered P2X1 receptor is preferentially activated by adenosine diphosphate in platelets and megakaryocytic cells. Blood. 98(1). 100–107. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact